| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/16/2003 | US6664234 Maintaining at or near isoelectric point |
| 12/16/2003 | US6664232 HLA-A2 restraint tumor antigen peptide originating in SART-1 |
| 12/16/2003 | US6664231 Based on Domain III (amino acids 142-169) of bactericidal/ permeability-increasing protein; candida, aspergillus, cryptococcus |
| 12/16/2003 | US6664230 Orally administered peptides to ameliorate atherosclerosis |
| 12/16/2003 | US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72 |
| 12/16/2003 | US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 12/16/2003 | US6664107 Insertion of exogenous DNA into genome of mammals producing transgenic mammals with decreased/suppressed endogenous gene expression and/or with expression of a novel gene(s); use in screening drugs for immunostimulatory effects |
| 12/16/2003 | US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
| 12/16/2003 | US6664098 Cellular differentiation and proliferation; ligands, membrane receptors; antigrowth agents; use of human Notch ligand, human Delta molecule, in development of drug candidates for differential regulation of undifferentiated cells |
| 12/16/2003 | US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 12/16/2003 | US6664089 Nucleotide sequences coding enzymatic proteins; for use in the treatment of cell proliferation and differention disorders; antiproliferative agents |
| 12/16/2003 | US6664087 Isolated human kinase proteins |
| 12/16/2003 | US6664084 Isolated nucleic acid molecules encoding human glucuronyltransferase proteins, and related products and processes |
| 12/16/2003 | US6664077 DNA encoding ACPL |
| 12/16/2003 | US6664075 Polypeptide binds to patched protein; genetic engineering |
| 12/16/2003 | US6664068 Antibodies, antiapoptotic agents |
| 12/16/2003 | US6664041 Method for preparing a viral extract containing HIV-II RNA |
| 12/16/2003 | US6664040 Complexing to polypeptides; antiproliferation agent |
| 12/16/2003 | US6663899 Controlled release microencapsulated NGF formulation |
| 12/16/2003 | US6663887 Compounds and compositions for delivering active agents |
| 12/16/2003 | US6663873 Antigenic preparation for treatment or prevention of helicobacter infection |
| 12/16/2003 | US6663871 Non-replicating or replication- impaired pox virus vector carrying at least one CD8 T cell epitope which is also present in the priming composition, malaria |
| 12/16/2003 | US6663870 Methods for promoting growth of bone using zvegf3 |
| 12/16/2003 | US6663869 Linkages between polypeptide organic molecules are oxime linkages formed by reaction of a keto, aldehyde or amino-oxy group on the amino acid |
| 12/16/2003 | US6663868 Heat shock protein-based vaccines and immunotherapies |
| 12/16/2003 | US6663867 Administering to a patient a hybrid protein comprising two different coexpressed amino acid sequences forming heterodimer, each comprising an amino acid sequence of tumor nacrosis factor binding protein and a subunit of hCG, FSG, LH |
| 12/16/2003 | US6663865 Tumor necrosis factor antagonists and their use in endometriosis |
| 12/16/2003 | US6663864 Crohn's disease, tumor necrosis factor, interleukins |
| 12/16/2003 | US6663858 Antitumor, gene therapy |
| 12/16/2003 | US6663857 In vivo gene transfer using implanted retroviral producer cells |
| 12/16/2003 | US6663850 Administering a compound that either inhibits the synthesis of ceramide, blocks the activity of ceramide, or degrades ceramide. |
| 12/16/2003 | CA2286879C Novel method for the production of anti-human antigen receptors and uses thereof |
| 12/16/2003 | CA2218737C Cytomodulating conjugates of members of specific binding pairs |
| 12/16/2003 | CA2096604C Protein c derivatives |
| 12/16/2003 | CA2088788C Peptides that block human immunodeficiency virus infections and methods of use thereof |
| 12/14/2003 | CA2432496A1 Diagnostic and therapeutic uses of sufu gene |
| 12/14/2003 | CA2430259A1 Vaccine |
| 12/11/2003 | WO2003102584A2 Semaphorin-like proteins and methods of using same |
| 12/11/2003 | WO2003102583A1 Targeted therapeutic proteins |
| 12/11/2003 | WO2003102579A2 Method of screening groups of radioactive molecules and applications thereof |
| 12/11/2003 | WO2003102538A2 Combinatorial chemical library ii |
| 12/11/2003 | WO2003102244A1 Antisense modulation of beta-site app-cleaving enzyme expression |
| 12/11/2003 | WO2003102242A1 Notch 1 inhibitors for inducing apopotosis |
| 12/11/2003 | WO2003102240A1 A method for identification of obese il-6 responsive patients |
| 12/11/2003 | WO2003102237A1 Treatment with cytokines |
| 12/11/2003 | WO2003102207A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 12/11/2003 | WO2003102206A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 12/11/2003 | WO2003102197A1 Transgenic plants with controlled distribution of a trait to progeny |
| 12/11/2003 | WO2003102195A1 Protein hydrolysate rich in tripeptides |
| 12/11/2003 | WO2003102189A1 Allergen from mugwort pollen |
| 12/11/2003 | WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 12/11/2003 | WO2003102186A1 Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
| 12/11/2003 | WO2003102185A2 Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules |
| 12/11/2003 | WO2003102180A1 NOVEL PEPTIDES HAVING cAMP PRODUCING ACTIVITY |
| 12/11/2003 | WO2003102173A2 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 12/11/2003 | WO2003102160A2 Rationally designed polysaccharide lyases derived from chondroitinase b |
| 12/11/2003 | WO2003102153A2 Cell migration inhibiting compositions and methods and compositions for treating cancer |
| 12/11/2003 | WO2003102149A2 Identification of a novel bhd gene |
| 12/11/2003 | WO2003102148A2 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 12/11/2003 | WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 12/11/2003 | WO2003102138A2 Elongase genes and uses thereof |
| 12/11/2003 | WO2003102135A2 Control sequences of the human corin gene |
| 12/11/2003 | WO2003102131A2 Nucleic acid mediated disruption of hiv fusogenic peptide interactions |
| 12/11/2003 | WO2003102129A2 Photorhabdus luminescens mcf toxin genes and uses thereof |
| 12/11/2003 | WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene |
| 12/11/2003 | WO2003102024A1 Combinatorial chemical library i |
| 12/11/2003 | WO2003102019A2 Antisense modulation of sterol regulatory element-binding protein-1 expression |
| 12/11/2003 | WO2003102016A2 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 12/11/2003 | WO2003102015A2 Method and apparatus for detecting and monitoring peptides, and peptides identified therewith |
| 12/11/2003 | WO2003102014A2 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 12/11/2003 | WO2003102008A1 Antisense modulation of transcription factor dp-1 expression |
| 12/11/2003 | WO2003101600A2 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 12/11/2003 | WO2003101488A1 Bacterial transforming agent |
| 12/11/2003 | WO2003101487A1 Use of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 12/11/2003 | WO2003101484A1 Compositions and methods for transepithelial molecular transport |
| 12/11/2003 | WO2003101483A1 Pharmaceutical preparation of botulinum neurotoxin, methods of synthesis and methods of clinical use |
| 12/11/2003 | WO2003101481A1 Treatment of neurodegenerative diseases using proteasome modulators |
| 12/11/2003 | WO2003101480A1 Topical drug delivery using phosphatidylcholine |
| 12/11/2003 | WO2003101479A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone |
| 12/11/2003 | WO2003101478A1 Treatment of hepatitis c in the asian population with subcutaneous interferonbeta |
| 12/11/2003 | WO2003101477A1 Use of uk114 in the treatment of leishmaniasis |
| 12/11/2003 | WO2003101475A1 Treatment of cell proliferative disorders with chlorotoxin |
| 12/11/2003 | WO2003101474A1 Combination chemotherapy with chlorotoxin |
| 12/11/2003 | WO2003101473A1 Suicide tetramers comprising mhc class i and uses thereof |
| 12/11/2003 | WO2003101429A1 A hemostatic composition |
| 12/11/2003 | WO2003101404A2 Preparations for topical skin use and treatment |
| 12/11/2003 | WO2003101402A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism |
| 12/11/2003 | WO2003101396A2 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 12/11/2003 | WO2003101395A2 Formulations for amylin agonist peptides |
| 12/11/2003 | WO2003101394A2 Defensins: use as antiviral agents |
| 12/11/2003 | WO2003101393A2 Antibacterial compounds and methods for treating gram positive bacterial infections |
| 12/11/2003 | WO2003101391A2 Therapeutic methods |
| 12/11/2003 | WO2003101387A2 Globulin protein to lower cholesterol in humans |
| 12/11/2003 | WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 12/11/2003 | WO2003101281A2 Method for reducing obstructive hydrocephalus |
| 12/11/2003 | WO2003101224A1 Dietary method for modulatng glucose metabolism and associated conditions and increasing longevity |
| 12/11/2003 | WO2003101202A1 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 12/11/2003 | WO2003101201A1 Intramyocardial injection of autologous bone marrow |
| 12/11/2003 | WO2003101199A1 Combination therapy for rna virus infections involving ribavirin and impdh inhibitors |
| 12/11/2003 | WO2003084984A8 Heterocyclic amides with alpha-4 integrin antagonist activity |